Side-by-side financials for ERNA and NVS. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ERNA | NVS |
|---|---|---|
| Market cap | - | $282.64 B |
| US-listed rank | - | #47 |
| Revenue (latest FY) | $582.00K | - |
| Net income (latest FY) | -$14.08M | - |
| Net margin | -2419.9% | - |
| SEC filings | 1,000 | 947 |
Full pages: Eterna Therapeutics Inc. and Novartis AG, or browse the full rankings.